Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Global Prevalence of HIV/AIDS and LYME Diseases
4.2.2 Increasing Demand for Automation of the Diagnosis and Analysis
4.3 Market Restraints
4.3.1 High cost of Labor and Automated Western Blotting Processors
4.3.2 Necessity to Update Regularly to Avoid Inconsistent and Skewed Results
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Automated Dry Blotting Systems
5.1.2 Semi-Dry Blotting Systems
5.1.3 Traditional Wet Transfer Blotting Systems
5.1.4 Others
5.2 By Application
5.2.1 Medical Diagnostics
5.2.2 Agricultural Application
5.2.3 Others
5.3 By End-user
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Academic and Research Institutes
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Analytik Jena AG
6.1.2 Cytoskeleton Inc
6.1.3 Bee Robotics Ltd
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 GE Healthcare
6.1.7 Protein Simple Inc. (Bio-Techne)
6.1.8 PerkinElmer Inc.
6.1.9 Expedeon AG
6.1.10 Merck KGaA


7 MARKET OPPORTUNITIES AND FUTURE TRENDS